Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Leukemia. 2010 Sep 23;24(12):2039–2047. doi: 10.1038/leu.2010.210

Table 4.

Predictors of a medical late effects among HCT survivors

All HCT Survivors Cataracts Dry eyes Dry mouth Hypothyroidism
OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value
Diagnosis
 AML referent referent referent referent
 ALL 0.86 0.5–1.5 0.6 0.76 0.4–1.5 0.4 0.97 0.4–2.1 0.94 1.07 0.6–1.9 0.8
Transplant type
 Autologous referent 0.3 referent referent referent
 Allogeneic 1.36 0.8–2.3 3.79 1.7–8.6 0.001 1.24 0.6–2.6 0.6 0.60 0.3–1.1 0.09
Conditioning regimen
 Chemotherapy only referent 0.004 referent referent referent
 Radiation & chemo 4.58 1.6–12.8 2.29 0.7–8.1 0.2 0.94 0.3–3.0 0.9 1.76 0.6–5.7 0.3
Sex
 Male referent referent referent referent
 Female 0.95 0.6–1.5 0.8 1.23 0.7–2.1 0.5 0.51 0.3–1.0 0.06 1.65 0.97–2.8 0.06
All HCT Survivors Diabetes Osteoporosis Avascular necrosis Exercise induced shortness of breath
OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value
Diagnosis
 AML referent referent referent referent
 ALL 0.54 0.2–1.3 0.2 1.01 0.4–2.3 0.98 0.27 0.1–1.0 0.06 2.03 0.9–4.6 0.09
Transplant type
 Autologous referent referent referent referent
 Allogeneic 3.92 1.1–14.0 0.04 3.10 1.0–9.4 0.05 5.38 1.2–25.0 0.03 1.03 0.4–2.7 0.9
Conditioning regimen
 Chemotherapy only NE referent referent referent
 Radiation & chemo 1.0 2.51 0.3–20.5 0.4 1.81 0.2–14.8 0.6 0.66 0.1–3.3 0.6
Sex
 Male referent referent referent referent
 Female 0.86 0.4–1.9 0.7 3.25 1.4–7.4 0.005 0.64 0.3–1.6 0.3 0.43 0.2–1.1 0.07